PE20020690A1 - Metodo y tratamiento y prevencion de los dolores de cabeza de migranas - Google Patents

Metodo y tratamiento y prevencion de los dolores de cabeza de migranas

Info

Publication number
PE20020690A1
PE20020690A1 PE2001001081A PE2001001081A PE20020690A1 PE 20020690 A1 PE20020690 A1 PE 20020690A1 PE 2001001081 A PE2001001081 A PE 2001001081A PE 2001001081 A PE2001001081 A PE 2001001081A PE 20020690 A1 PE20020690 A1 PE 20020690A1
Authority
PE
Peru
Prior art keywords
cycloalkyl
alkyl
ch2cf3
headaches
prevention
Prior art date
Application number
PE2001001081A
Other languages
English (en)
Inventor
Kjell A Sevensson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PE20020690A1 publication Critical patent/PE20020690A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UN METODO DE PREVENCION DE LA OCURRENCIA DE DOLORES DE CABEZA Y MIGRANA QUE COMPRENDE UN COMPUESTO DE FORMULA I DONDE R1 Y R2 SON H, OH, CN, CH2CN, 2-CF3, CH2CF3, CH2CHF2, HC=CF2, (CH2)2CF3, ETENILO, 2-PROPENILO, OSO2CH3, OSO2CF3, COR, O(CH2)xCF3, CONH2, SOxCH3, ENTRE OTROS; x ES 0-2; R3 ES H, CF3, CH2CF3, ALQUILO C1-C8, CICLOALQUILO C3-C8, CICLOALQUIL C4-C9-METILO, ALQUENILO C2-C8, ALQUINILO C2-C8, (CH2)m-R5; m ES 1-8; R5 ES CN, CF3, CH2CF3, ALQUILO C1-C8, CICLOALQUILO C3-C8, 2-TIOFENILO, NR6CONR6R7; R6 Y R7 SON H, ALQUILO C1-C8, CICLOALQUILO C3-C8, ALQUENILO C2-C8; n ES 1-2; R4 Y R SON H, CF3, CH2CF3, ALQUILO C1-C8, CICLOALQUILO C3-C8, CICLOALQUIL C4-C9-METILO; SIENDO UN COMPUESTO PREFERIDO S-(-)-3-[3-(METILSULFONIL)FENIL]-1-PROPIL-PIPERIDINA; UTILIZANDOSE DE 0,5mg A 2mg; TAMBIEN SE REFIERE AL USO CON UN ANALGESICO, ANTIINFLAMATORIO, ERGOTAMINA, TRIPTAN
PE2001001081A 2000-11-03 2001-10-31 Metodo y tratamiento y prevencion de los dolores de cabeza de migranas PE20020690A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24596700P 2000-11-03 2000-11-03

Publications (1)

Publication Number Publication Date
PE20020690A1 true PE20020690A1 (es) 2002-08-23

Family

ID=22928823

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001001081A PE20020690A1 (es) 2000-11-03 2001-10-31 Metodo y tratamiento y prevencion de los dolores de cabeza de migranas

Country Status (7)

Country Link
US (1) US6589965B2 (es)
EP (1) EP1335721A4 (es)
JP (1) JP2004518636A (es)
AU (1) AU2002232457A1 (es)
CA (1) CA2426894A1 (es)
PE (1) PE20020690A1 (es)
WO (1) WO2002036071A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
US20050065094A1 (en) 2003-09-05 2005-03-24 Boehringer Ingelheim International Gmbh Use of telmisartan for the prevention and treatment of vascular headache
KR101336991B1 (ko) * 2007-05-16 2013-12-16 삼성전자주식회사 교차점 래치 및 그의 동작 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0395734A4 (en) * 1988-01-15 1991-01-02 Abbott Laboratories 1-aminomethyl-1,2,3,4-tetrahydronaphthalenes
ATE201669T1 (de) * 1991-04-17 2001-06-15 Upjohn Co Substituierte (s)-3-phenylpiperidin derivate, deren herstellung und deren verwendung als dopamin autorezeptor antagonisten
SE9904724D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I

Also Published As

Publication number Publication date
JP2004518636A (ja) 2004-06-24
US6589965B2 (en) 2003-07-08
EP1335721A2 (en) 2003-08-20
AU2002232457A1 (en) 2002-05-15
WO2002036071A3 (en) 2002-07-25
CA2426894A1 (en) 2002-05-10
US20020091140A1 (en) 2002-07-11
EP1335721A4 (en) 2005-09-14
WO2002036071A2 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
DE69325454D1 (de) Taxol-derivate
AR240929A2 (es) "n-piridinsulfonil-n'-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas"
PE20021091A1 (es) Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
PT869946E (pt) Fenilimidazolidinas e sua utilizacao como agentes anti-androgenicos
EA199900620A1 (ru) Фталазиноны
EA199800667A1 (ru) Новые фенантридины
UY34152A (es) ?oxazolidinonas substituidas y su uso?.
DE69925133D1 (de) Pyrrolobenzodiazepine
ES2053094T3 (es) Agentes ansioliticos y antidepresivos bis-aza-biciclicos.
ES2158284T3 (es) Metil-fenil-oxazolidinonas quirales.
EA199900421A1 (ru) Бензонафтиридины в качестве бронхиальных терапевтических средств
NO20072255L (no) Sammensetning omfattende acetaminofen, koffein og valgfritt aspirin sammen med et alkalisk middel for forbedret absorpsjon
CO5140075A1 (es) Agentes terapeuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas
SV2002000244A (es) Metodos y compuestos para inhibir mrp1 ref.x-13353
CO4950553A1 (es) Compuestos de 7-tetrahidroisoquinolinas y procedimiento para su preparacion
JPS5382419A (en) Blade cleaning device
MX9100710A (es) Agentes fitoprotectores que contienen isoxazolinas o isotiazolinas asi como nuevas isoxazolinas e isotiazolinas
EA200000042A1 (ru) Способ лечения диабета росиглитазоном и инсулином
PE20020690A1 (es) Metodo y tratamiento y prevencion de los dolores de cabeza de migranas
EA200100947A1 (ru) Жевательные таблетки с высоким содержанием n-ацетилцистеина
EA200100297A1 (ru) Моногидрат гидробромида элетриптана
EA199901116A1 (ru) Композиция, включающая 5-[4-[2-(n-метил-n-2-пиридил)-амино)этокси]бензил]тиазолидин-2,4-дион
CO5271679A1 (es) Inhibidores de proteasa 7-14 miembros
AR001259A1 (es) Proceso para preparar 1,2-bencisotiazolin-3-onas
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE

Legal Events

Date Code Title Description
FC Refusal